APO Research

APO RESEARCH · REPORT

Polymyxin B Sulfate

Selected research

Market Structure

Global Polymyxin B Sulfate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Polymyxin B Sulfate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Polymyxin B Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Polymyxin B Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Polymyxin B Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Polymyxin B Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Polymyxin B Sulfate include AKORN, XELLIA PHARMS APS, SANDOZ INC, FRESENIUS KABI USA, Concord Biotech, BAUSCH AND LOMB, AuroMedics and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Polymyxin B Sulfate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Polymyxin B Sulfate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Polymyxin B Sulfate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Polymyxin B Sulfate market size, projected growth trends, production technologies, key applications, and end-use industries.

Polymyxin B Sulfate Segment by Company

AKORN

XELLIA PHARMS APS

SANDOZ INC

FRESENIUS KABI USA

Concord Biotech

BAUSCH AND LOMB

AuroMedics

Allergan

Polymyxin B Sulfate Segment by Type

Tablets

Injections

Polymyxin B Sulfate Segment by Application

Hospitals

Private Clinics

Others

Polymyxin B Sulfate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymyxin B Sulfate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polymyxin B Sulfate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymyxin B Sulfate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Polymyxin B Sulfate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Polymyxin B Sulfate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Polymyxin B Sulfate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Polymyxin B Sulfate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Polymyxin B Sulfate Industry Trends Table 2. Polymyxin B Sulfate Industry Drivers Table 3. Polymyxin B Sulfate Industry Opportunities and Challenges Table 4. Polymyxin B Sulfate Industry Restraints Table 5. Global Polymyxin B Sulfate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Polymyxin B Sulfate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Polymyxin B Sulfate Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Polymyxin B Sulfate Sales Market Share by Manufacturers Table 9. Global Polymyxin B Sulfate Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Polymyxin B Sulfate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Polymyxin B Sulfate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Polymyxin B Sulfate Manufacturers, Product Type & Application Table 13. Global Polymyxin B Sulfate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Polymyxin B Sulfate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Injections Table 18. Global Polymyxin B Sulfate Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Polymyxin B Sulfate Sales by Type (2021-2026) & (K Units) Table 20. Global Polymyxin B Sulfate Sales by Type (2027-2032) & (K Units) Table 21. Global Polymyxin B Sulfate Sales Market Share by Type (2021-2026) Table 22. Global Polymyxin B Sulfate Sales Market Share by Type (2027-2032) Table 23. Global Polymyxin B Sulfate Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Polymyxin B Sulfate Revenue by Type (2021-2026) & (K Units) Table 25. Global Polymyxin B Sulfate Revenue by Type (2027-2032) & (K Units) Table 26. Global Polymyxin B Sulfate Revenue Market Share by Type (2021-2026) Table 27. Global Polymyxin B Sulfate Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Private Clinics Table 30. Major Manufacturers of Others Table 31. Global Polymyxin B Sulfate Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Polymyxin B Sulfate Sales by Application (2021-2026) & (K Units) Table 33. Global Polymyxin B Sulfate Sales by Application (2027-2032) & (K Units) Table 34. Global Polymyxin B Sulfate Sales Market Share by Application (2021-2026) Table 35. Global Polymyxin B Sulfate Sales Market Share by Application (2027-2032) Table 36. Global Polymyxin B Sulfate Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Polymyxin B Sulfate Revenue by Application (2021-2026) & (K Units) Table 38. Global Polymyxin B Sulfate Revenue by Application (2027-2032) & (K Units) Table 39. Global Polymyxin B Sulfate Revenue Market Share by Application (2021-2026) Table 40. Global Polymyxin B Sulfate Revenue Market Share by Application (2027-2032) Table 41. Global Polymyxin B Sulfate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Polymyxin B Sulfate Sales by Region (2021-2026) & (K Units) Table 43. Global Polymyxin B Sulfate Sales Market Share by Region (2021-2026) Table 44. Global Polymyxin B Sulfate Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Polymyxin B Sulfate Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Polymyxin B Sulfate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Polymyxin B Sulfate Sales by Country (2021-2026) & (K Units) Table 48. North America Polymyxin B Sulfate Sales by Country (2027-2032) & (K Units) Table 49. Europe Polymyxin B Sulfate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Polymyxin B Sulfate Sales by Country (2021-2026) & (K Units) Table 51. Europe Polymyxin B Sulfate Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Polymyxin B Sulfate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Polymyxin B Sulfate Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Polymyxin B Sulfate Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Polymyxin B Sulfate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Polymyxin B Sulfate Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Polymyxin B Sulfate Sales by Country (2027-2032) & (K Units) Table 58. Global Polymyxin B Sulfate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Polymyxin B Sulfate Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Polymyxin B Sulfate Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Polymyxin B Sulfate Revenue Market Share by Region (2021-2026) Table 62. Global Polymyxin B Sulfate Revenue Market Share by Region (2027-2032) Table 63. AKORN Company Information Table 64. AKORN Business Overview Table 65. AKORN Polymyxin B Sulfate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. AKORN Polymyxin B Sulfate Product Portfolio Table 67. AKORN Recent Development Table 68. XELLIA PHARMS APS Company Information Table 69. XELLIA PHARMS APS Business Overview Table 70. XELLIA PHARMS APS Polymyxin B Sulfate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. XELLIA PHARMS APS Polymyxin B Sulfate Product Portfolio Table 72. XELLIA PHARMS APS Recent Development Table 73. SANDOZ INC Company Information Table 74. SANDOZ INC Business Overview Table 75. SANDOZ INC Polymyxin B Sulfate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. SANDOZ INC Polymyxin B Sulfate Product Portfolio Table 77. SANDOZ INC Recent Development Table 78. FRESENIUS KABI USA Company Information Table 79. FRESENIUS KABI USA Business Overview Table 80. FRESENIUS KABI USA Polymyxin B Sulfate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. FRESENIUS KABI USA Polymyxin B Sulfate Product Portfolio Table 82. FRESENIUS KABI USA Recent Development Table 83. Concord Biotech Company Information Table 84. Concord Biotech Business Overview Table 85. Concord Biotech Polymyxin B Sulfate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Concord Biotech Polymyxin B Sulfate Product Portfolio Table 87. Concord Biotech Recent Development Table 88. BAUSCH AND LOMB Company Information Table 89. BAUSCH AND LOMB Business Overview Table 90. BAUSCH AND LOMB Polymyxin B Sulfate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. BAUSCH AND LOMB Polymyxin B Sulfate Product Portfolio Table 92. BAUSCH AND LOMB Recent Development Table 93. AuroMedics Company Information Table 94. AuroMedics Business Overview Table 95. AuroMedics Polymyxin B Sulfate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. AuroMedics Polymyxin B Sulfate Product Portfolio Table 97. AuroMedics Recent Development Table 98. Allergan Company Information Table 99. Allergan Business Overview Table 100. Allergan Polymyxin B Sulfate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Allergan Polymyxin B Sulfate Product Portfolio Table 102. Allergan Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Polymyxin B Sulfate Distributors List Table 106. Polymyxin B Sulfate Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Polymyxin B Sulfate Product Image Figure 2. Global Polymyxin B Sulfate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polymyxin B Sulfate Market Size (2021-2032) & (US$ Million) Figure 4. Global Polymyxin B Sulfate Sales (2021-2032) & (K Units) Figure 5. Global Polymyxin B Sulfate Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Polymyxin B Sulfate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Injections Image Figure 10. Global Polymyxin B Sulfate Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Polymyxin B Sulfate Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Polymyxin B Sulfate Sales Market Share by Type (2021-2032) Figure 13. Global Polymyxin B Sulfate Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Polymyxin B Sulfate Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Polymyxin B Sulfate Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Private Clinics Image Figure 18. Others Image Figure 19. Global Polymyxin B Sulfate Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Polymyxin B Sulfate Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Polymyxin B Sulfate Sales Market Share by Application (2021-2032) Figure 22. Global Polymyxin B Sulfate Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Polymyxin B Sulfate Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Polymyxin B Sulfate Revenue Market Share by Application (2021-2032) Figure 25. North America Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Polymyxin B Sulfate Sales Market Share by Country (2021-2032) Figure 27. U.S. Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Polymyxin B Sulfate Sales Market Share by Country (2021-2032) Figure 32. Germany Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Polymyxin B Sulfate Sales Market Share by Country (2021-2032) Figure 39. China Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Polymyxin B Sulfate Sales Market Share by Country (2021-2032) Figure 47. Brazil Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Polymyxin B Sulfate Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Polymyxin B Sulfate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Polymyxin B Sulfate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Polymyxin B Sulfate Revenue (2021-2032) & (US$ Million) Figure 58. North America Polymyxin B Sulfate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Polymyxin B Sulfate Revenue (2021-2032) & (US$ Million) Figure 60. Europe Polymyxin B Sulfate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Polymyxin B Sulfate Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Polymyxin B Sulfate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Polymyxin B Sulfate Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Polymyxin B Sulfate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Polymyxin B Sulfate Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Polymyxin B Sulfate Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injections
Applications
  • Hospitals
  • Private Clinics
  • Others
Companies covered
  • AKORN
  • XELLIA PHARMS APS
  • SANDOZ INC
  • FRESENIUS KABI USA
  • Concord Biotech
  • BAUSCH AND LOMB
  • AuroMedics
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Polymyxin B Sulfate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Polymyxin B Sulfate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Polymyxin B Sulfate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Polymyxin B Sulfate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Polymyxin B Sulfate Market Dynamics
  1. 2.1 Polymyxin B Sulfate Industry Trends
  2. 2.2 Polymyxin B Sulfate Industry Drivers
  3. 2.3 Polymyxin B Sulfate Industry Opportunities and Challenges
  4. 2.4 Polymyxin B Sulfate Industry Restraints
3 Polymyxin B Sulfate Market by Manufacturers
  1. 3.1 Global Polymyxin B Sulfate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Polymyxin B Sulfate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Polymyxin B Sulfate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Polymyxin B Sulfate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Polymyxin B Sulfate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Polymyxin B Sulfate Manufacturers, Product Type & Application
  7. 3.7 Global Polymyxin B Sulfate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Polymyxin B Sulfate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Polymyxin B Sulfate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Polymyxin B Sulfate Tier 1, Tier 2, and Tier 3
4 Polymyxin B Sulfate Market by Type
  1. 4.1 Polymyxin B Sulfate Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Injections
  4. 4.2 Global Polymyxin B Sulfate Sales by Type
  5. 4.2.1 Global Polymyxin B Sulfate Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Polymyxin B Sulfate Sales by Type (2021-2032)
  7. 4.2.3 Global Polymyxin B Sulfate Sales Market Share by Type (2021-2032)
  8. 4.3 Global Polymyxin B Sulfate Revenue by Type
  9. 4.3.1 Global Polymyxin B Sulfate Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Polymyxin B Sulfate Revenue by Type (2021-2032)
  11. 4.3.3 Global Polymyxin B Sulfate Revenue Market Share by Type (2021-2032)
5 Polymyxin B Sulfate Market by Application
  1. 5.1 Polymyxin B Sulfate Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Private Clinics
  4. 5.1.3 Others
  5. 5.2 Global Polymyxin B Sulfate Sales by Application
  6. 5.2.1 Global Polymyxin B Sulfate Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Polymyxin B Sulfate Sales by Application (2021-2032)
  8. 5.2.3 Global Polymyxin B Sulfate Sales Market Share by Application (2021-2032)
  9. 5.3 Global Polymyxin B Sulfate Revenue by Application
  10. 5.3.1 Global Polymyxin B Sulfate Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Polymyxin B Sulfate Revenue by Application (2021-2032)
  12. 5.3.3 Global Polymyxin B Sulfate Revenue Market Share by Application (2021-2032)
6 Global Polymyxin B Sulfate Sales by Region
  1. 6.1 Global Polymyxin B Sulfate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Polymyxin B Sulfate Sales by Region (2021-2032)
  3. 6.2.1 Global Polymyxin B Sulfate Sales by Region (2021-2026)
  4. 6.2.2 Global Polymyxin B Sulfate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Polymyxin B Sulfate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Polymyxin B Sulfate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Polymyxin B Sulfate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Polymyxin B Sulfate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Polymyxin B Sulfate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Polymyxin B Sulfate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Polymyxin B Sulfate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Polymyxin B Sulfate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Polymyxin B Sulfate Revenue by Region
  1. 7.1 Global Polymyxin B Sulfate Revenue by Region
  2. 7.1.1 Global Polymyxin B Sulfate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Polymyxin B Sulfate Revenue by Region (2021-2026)
  4. 7.1.3 Global Polymyxin B Sulfate Revenue by Region (2027-2032)
  5. 7.1.4 Global Polymyxin B Sulfate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Polymyxin B Sulfate Revenue (2021-2032)
  8. 7.2.2 North America Polymyxin B Sulfate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Polymyxin B Sulfate Revenue (2021-2032)
  11. 7.3.2 Europe Polymyxin B Sulfate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Polymyxin B Sulfate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Polymyxin B Sulfate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Polymyxin B Sulfate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Polymyxin B Sulfate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AKORN
  2. 8.1.1 AKORN Company Information
  3. 8.1.2 AKORN Business Overview
  4. 8.1.3 AKORN Polymyxin B Sulfate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AKORN Polymyxin B Sulfate Product Portfolio
  6. 8.1.5 AKORN Recent Developments
  7. 8.2 XELLIA PHARMS APS
  8. 8.2.1 XELLIA PHARMS APS Company Information
  9. 8.2.2 XELLIA PHARMS APS Business Overview
  10. 8.2.3 XELLIA PHARMS APS Polymyxin B Sulfate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 XELLIA PHARMS APS Polymyxin B Sulfate Product Portfolio
  12. 8.2.5 XELLIA PHARMS APS Recent Developments
  13. 8.3 SANDOZ INC
  14. 8.3.1 SANDOZ INC Company Information
  15. 8.3.2 SANDOZ INC Business Overview
  16. 8.3.3 SANDOZ INC Polymyxin B Sulfate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SANDOZ INC Polymyxin B Sulfate Product Portfolio
  18. 8.3.5 SANDOZ INC Recent Developments
  19. 8.4 FRESENIUS KABI USA
  20. 8.4.1 FRESENIUS KABI USA Company Information
  21. 8.4.2 FRESENIUS KABI USA Business Overview
  22. 8.4.3 FRESENIUS KABI USA Polymyxin B Sulfate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 FRESENIUS KABI USA Polymyxin B Sulfate Product Portfolio
  24. 8.4.5 FRESENIUS KABI USA Recent Developments
  25. 8.5 Concord Biotech
  26. 8.5.1 Concord Biotech Company Information
  27. 8.5.2 Concord Biotech Business Overview
  28. 8.5.3 Concord Biotech Polymyxin B Sulfate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Concord Biotech Polymyxin B Sulfate Product Portfolio
  30. 8.5.5 Concord Biotech Recent Developments
  31. 8.6 BAUSCH AND LOMB
  32. 8.6.1 BAUSCH AND LOMB Company Information
  33. 8.6.2 BAUSCH AND LOMB Business Overview
  34. 8.6.3 BAUSCH AND LOMB Polymyxin B Sulfate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BAUSCH AND LOMB Polymyxin B Sulfate Product Portfolio
  36. 8.6.5 BAUSCH AND LOMB Recent Developments
  37. 8.7 AuroMedics
  38. 8.7.1 AuroMedics Company Information
  39. 8.7.2 AuroMedics Business Overview
  40. 8.7.3 AuroMedics Polymyxin B Sulfate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AuroMedics Polymyxin B Sulfate Product Portfolio
  42. 8.7.5 AuroMedics Recent Developments
  43. 8.8 Allergan
  44. 8.8.1 Allergan Company Information
  45. 8.8.2 Allergan Business Overview
  46. 8.8.3 Allergan Polymyxin B Sulfate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Allergan Polymyxin B Sulfate Product Portfolio
  48. 8.8.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Polymyxin B Sulfate Value Chain Analysis
  2. 9.1.1 Polymyxin B Sulfate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Polymyxin B Sulfate Production Mode & Process
  6. 9.2 Polymyxin B Sulfate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Polymyxin B Sulfate Distributors
  9. 9.2.3 Polymyxin B Sulfate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research